Key facts
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Know Rare
- ·The full record, as it builds
Funding rounds
No funding rounds for Know Rare are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Know Rare
Developer of a rare disease support platform designed for patients and researchers with the discovery of new therapies for rare diseases. The company's platform allows people to chat instantly, track, communicate and connect with healthcare providers, caregivers and loved ones as well as learn about living and thriving with rare diseases, thereby ensuring an accessible, ethical recruitment and a rewarding experience for people with rare diseases.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2020
- Employees
- 14
- Website
- knowrare.com/
- Ownership
- Privately Held (backing)
Know Rare doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Know Rare shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Know Rare in its N-PORT filings yet. We sweep new filings monthly.